News
Current position:Product Center > Antibodies > Anti-payload antibodies > Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]
Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]
Product info

Cat.No:GM-81148AB

Product:Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]




Cat. No. & Size

GM-81148AB-100        100μg

GM-81148AB-1mg       1mg

Description️

Expression System                               CHO

Aggregation                                         < 5% as determined by SEC-HPLC

Purity                                                    >95% as determined by SDS-PAGE

Drug-to-Antibody Ratio (DAR)           4.0

Endotoxin                                            <1 EU/mg, determined by LAL gel clotting assay

Sterility                                                  0.22 μm Filtered

Target                                                    Tissue Factor (TF)

Clone                                                     Tisotumab vedotin

Alternative Names                               TF-011-MMAE; HuMax-TF-ADC

Antibody Type/ Isotype                       Monoclonal Human IgG1(REEM),Kappa

Description                                            Tisotumab vedotin is an antibody-drug conjugate used to treat cervical cancer. It is a combination of tisotumab, a monoclonal antibody against tissue factor, and monomethyl auristatin E (MMAE), a potent inhibitor of cell division. It is administered by infusion into a vein.

Formulation                                          20 mM Histidine, pH 6.0

Storage temp.                                       Store at +4°C short term. Store at -80°C for 36 months, avoiding freeze/thaw cycles.

Data

GM-81148AB-1.jpg


/ueditor/image/20240524/1716514638748697/2b07bb881eed5a7d95b96283e6ec9fba.png


/ueditor/image/20240524/1716514660941500/cb81add86c9693cd797248168ca7c2e6.png

Current position:Product Center > -- > Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]
classify
Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]
Product info

Cat.No:GM-81148AB

Product:Anti-TF-MMAE ADC(Dar4)[Tisotumab vedotin]




Cat. No. & Size

GM-81148AB-100        100μg

GM-81148AB-1mg       1mg

Description️

Expression System                               CHO

Aggregation                                         < 5% as determined by SEC-HPLC

Purity                                                    >95% as determined by SDS-PAGE

Drug-to-Antibody Ratio (DAR)           4.0

Endotoxin                                            <1 EU/mg, determined by LAL gel clotting assay

Sterility                                                  0.22 μm Filtered

Target                                                    Tissue Factor (TF)

Clone                                                     Tisotumab vedotin

Alternative Names                               TF-011-MMAE; HuMax-TF-ADC

Antibody Type/ Isotype                       Monoclonal Human IgG1(REEM),Kappa

Description                                            Tisotumab vedotin is an antibody-drug conjugate used to treat cervical cancer. It is a combination of tisotumab, a monoclonal antibody against tissue factor, and monomethyl auristatin E (MMAE), a potent inhibitor of cell division. It is administered by infusion into a vein.

Formulation                                          20 mM Histidine, pH 6.0

Storage temp.                                       Store at +4°C short term. Store at -80°C for 36 months, avoiding freeze/thaw cycles.

Data

GM-81148AB-1.jpg


/ueditor/image/20240524/1716514638748697/2b07bb881eed5a7d95b96283e6ec9fba.png


/ueditor/image/20240524/1716514660941500/cb81add86c9693cd797248168ca7c2e6.png

Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit